By What Percentage Did CVS’s Revenue & EBITDA Grow In The Last 5 Years?

+11.00%
Upside
79.43
Market
88.17
Trefis
CVS: CVS Health logo
CVS
CVS Health

Revenue Growth: ~10% CAGR [Growth driven primarily by increase in Pharmacy Services (PBM) Revenue]
EBITDA Growth: <10% CAGR [ Growth driven by an increase in Prescription Drugs & Pharmacy Services EBITDA]

cvs-q3

Have more questions about CVS Health (NYSE:CVS)? Click on the links below:

Relevant Articles
  1. Should You Pick CVS Stock At $75 After A 6% Fall This Year?
  2. Is CVS Health Stock Undervalued At $70?
  3. Will CVS Health Stock Recover To Its Pre-Inflation Shock Highs of $110?
  4. Higher Costs To Weigh On CVS Health’s Q2?
  5. Should You Buy CVS Stock At $70?
  6. Will CVS Stock Rise Post Q1?

Notes:

1) The purpose of these analyses is to help readers focus on a few important things. We hope such lean communication sparks thinking, and encourages readers to comment and ask questions on the comment section, or email content@trefis.com

2) Figures mentioned are approximate values to help our readers remember the key concepts more intuitively. For precise figures, please refer to our detailed analysis for CVS Health

See More at Trefis | View Interactive Institutional Research (Powered by Trefis) Get Trefis Technology